Related references
Note: Only part of the references are listed.DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics
Michio Iwata et al.
SCIENTIFIC REPORTS (2017)
Principal Components Analysis Based Unsupervised Feature Extraction Applied to Gene Expression Analysis of Blood from Dengue Haemorrhagic Fever Patients
Y-h. Taguchi
SCIENTIFIC REPORTS (2017)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data
Hans De Wolf et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Inferring gene targets of drugs and chemical compounds from gene expression profiles
Heeju Noh et al.
BIOINFORMATICS (2016)
Drug-induced adverse events prediction with the LINCS L1000 data
Zichen Wang et al.
BIOINFORMATICS (2016)
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Paul G. O'Reilly et al.
BMC BIOINFORMATICS (2016)
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
Y-h Taguchi et al.
BMC MEDICAL GENOMICS (2016)
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
Alexander Aliper et al.
MOLECULAR PHARMACEUTICS (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
g:Profiler-a web server for functional interpretation of gene lists (2016 update)
Juri Reimand et al.
NUCLEIC ACIDS RESEARCH (2016)
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine
Yao-Yu Hsieh et al.
ONCOTARGET (2016)
Principal component analysis based unsupervised feature extraction applied to budding yeast temporally periodic gene expression
Y-h Taguchi
BIODATA MINING (2016)
L1000CDS(2): LINCS L1000 characteristic direction signatures search engine
Qiaonan Duan et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2016)
Identification of More Feasible MicroRNA-mRNA Interactions within Multiple Cancers Using Principal Component Analysis Based Unsupervised Feature Extraction
Y-h. Taguchi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Systematic Quality Control Analysis of LINCS Data
L. Cheng et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
microRNA-mRNA interaction identification in Wilms tumor using principal component analysis based unsupervised feature extraction
Y-h. Taguchi
2016 IEEE 16TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING (BIBE) (2016)
DSigDB: drug signatures database for gene set analysis
Minjae Yoo et al.
BIOINFORMATICS (2015)
Identification of aberrant gene expression associated with aberrant promoter methylation in primordial germ cells between E13 and E16 rat F3 generation vinclozolin lineage
Y-h Taguchi
BMC BIOINFORMATICS (2015)
Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease
Y-h Taguchi et al.
BMC BIOINFORMATICS (2015)
Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner
Yoshiyuki Hizukuri et al.
BMC MEDICAL GENOMICS (2015)
Elucidating Compound Mechanism of Action by Network Perturbation Analysis
Jung Hoon Woo et al.
CELL (2015)
Compound signature detection on LINCS L1000 big data
Chenglin Liu et al.
MOLECULAR BIOSYSTEMS (2015)
Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
Yoshiki Murakami et al.
SCIENTIFIC REPORTS (2015)
Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells
Jennifer L. Ali et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network
Helge G. Roider et al.
BMC BIOINFORMATICS (2014)
The characteristic direction: a geometrical approach to identify differentially expressed genes
Neil R. Clark et al.
BMC BIOINFORMATICS (2014)
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer
Hideaki Umeyama et al.
BMC GENOMICS (2014)
Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets
Ryoichi Kinoshita et al.
BMC SYSTEMS BIOLOGY (2014)
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Evanthia Lionta et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes
Iakes Ezkurdia et al.
HUMAN MOLECULAR GENETICS (2014)
STITCH 4: integration of protein-chemical interactions with user data
Michael Kuhn et al.
NUCLEIC ACIDS RESEARCH (2014)
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
Qiaonan Duan et al.
NUCLEIC ACIDS RESEARCH (2014)
Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer
Gary Wildey et al.
PLOS ONE (2014)
Integrating Genomics and Proteomics Data to Predict Drug Effects Using Binary Linear Programming
Zhiwei Ji et al.
PLOS ONE (2014)
Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray
Yoshiki Murakami et al.
PLOS ONE (2014)
Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
Shigeharu Ishida et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Systematic evaluation of connectivity map for disease indications
Jie Cheng et al.
GENOME MEDICINE (2014)
Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies
Geoffrey T. Gibney et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Emerging drug profile: cyclin-dependent kinase inhibitors
James S. Blachly et al.
LEUKEMIA & LYMPHOMA (2013)
SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations
Joachim von Eichborn et al.
NUCLEIC ACIDS RESEARCH (2013)
Principal Component Analysis Based Feature Extraction Approach to Identify Circulating microRNA Biomarkers
Y-h. Taguchi et al.
PLOS ONE (2013)
InChI - the worldwide chemical structure identifier standard
Stephen Heller et al.
JOURNAL OF CHEMINFORMATICS (2013)
Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
Kejian Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease
Yoshiki Murakami et al.
PLOS ONE (2012)
Theoretical and computational approaches to ligand-based drug discovery
Angelo D. Favia
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
L. Santo et al.
ONCOGENE (2010)
Discovery of drug mode of action and drug repositioning from transcriptional responses
Francesco Iorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
KEA: kinase enrichment analysis
Alexander Lachmann et al.
BIOINFORMATICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors
GH Kuo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy
P Stanetty et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase -: 2.: N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent
RN Misra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy
AR Tan et al.
SEMINARS IN ONCOLOGY (2002)
Share Paper
